
Innovative Treatments and Future Directions for Late-Onset Hypogonadism in American Males
Reading Time: 2 minutes Introduction to Late-Onset Hypogonadism Late-onset hypogonadism (LOH), often referred to as age-related low testosterone, is a clinical and biochemical syndrome characterized by a deficiency in serum testosterone levels in conjunction with specific signs and symptoms. As American males age, the prevalence of LOH increases, leading to a growing interest in effective treatment modalities. This article delves into the evolving landscape of LOH treatment, spotlighting innovative approaches and future directions. Current Treatment Landscape Currently, the primary treatment for LOH in the United States involves testosterone replacement therapy (TRT). TRT has been shown to improve symptoms such as reduced libido, fatigue, and...